| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RDZN | Ordinary Shares | Purchase | $6.18K | +6K | +49.79% | $1.03 | 18.1K | Feb 27, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RDZN | Warrants | Purchase | $36.00 | +600 | +10.43% | $0.06 | 6.35K | Feb 27, 2025 | Ordinary Shares | 600 | $11.50 | Direct | F2, F3 |
| holding | RDZN | Convertible Debentures | $500K | Feb 27, 2025 | Ordinary Shares | 58.8K | $8.50 | Direct | ||||||
| holding | RDZN | Warrants | 100K | Feb 27, 2025 | Ordinary Shares | 100K | Direct | F4, F5 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.09, inclusive. The reporting person undertakes to provide to Roadzen Inc., any security holder of Roadzen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | The warrants to purchase Ordinary Shares of Roadzen Inc. (the "Public Warrants"), are exercisable for a whole number of Ordinary Shares at any time (subject to certain exceptions provided by the governing warrant agreement). |
| F3 | The Public Warrants will expire on September 20, 2028, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. |
| F4 | The exercise price of the warrants reported herein (the "Warrants") is equal to 80% of the lower of (i) the volume-weighted average price ("VWAP") of the ordinary shares of the Issuer, as reported on relevant market or exchange, over the 60 trading days subsequent to the first loan funding under the Notes (as defined below), (ii) the opening price of the Issuer's ordinary shares, as reported on the relevant market or exchange, in any public offering of straight equity securities of the Issuer occurring within six months after the issue date of the warrants and (iii) the VWAP of the Issuer's ordinary shares, as reported on the relevant market or exchange, over the 60 trading days immediately prior to the Vesting Date (as defined below). |
| F5 | The Warrants are exercisable in full on March 28, 2025, or earlier under certain circumstances (as applicable, the "Vesting Date"). |